Medical Advisory Board VIRxSYS has assembled a Medical Advisory Board comprised of experts in HIV medicine. The Medical Advisory Board offers guidance in the design and execution of the Company’s HIV clinical trials, and guidance in positioning VRX496. The members of the Medical Advisory Board […]
Month: September 2020
Intellectual Property
VIRxSYS has developed an extensive portfolio of intellectual property which is protected by a combination of patents, trade secrets, and trademark law. Below is a summary of the Company’s parent patents in the United States. VIRxSYS also has many foreign counterparts in countries around the […]
Manufacturing Facilities
VIRxSYS is the only company currently testing a lentiviral vector permitted for use by the FDA in Phase II clinical trials. Consequently, VIRxSYS is uniquely positioned to manufacture clinical-grade lentiviral vectors for therapies treating a wide range of life-threatening diseases. VIRxSYS is initially focused on […]